Cargando…
Binding site residues control inhibitor selectivity in the human norepinephrine transporter but not in the human dopamine transporter
The transporters for norepinephrine and dopamine (NET and DAT, respectively) constitute the molecular targets for recreational drugs and therapeutics used in the treatment of psychiatric disorders. Despite a strikingly similar amino acid sequence and predicted topology between these transporters, so...
Autores principales: | Andersen, Jacob, Ringsted, Kristoffer B., Bang-Andersen, Benny, Strømgaard, Kristian, Kristensen, Anders S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4621520/ https://www.ncbi.nlm.nih.gov/pubmed/26503701 http://dx.doi.org/10.1038/srep15650 |
Ejemplares similares
-
Genetically encoded photocrosslinkers locate the high-affinity binding site of antidepressant drugs in the human serotonin transporter
por: Rannversson, Hafsteinn, et al.
Publicado: (2016) -
Structure-Function of the High Affinity Substrate Binding Site (S1) of Human Norepinephrine Transporter
por: Jha, Prerna, et al.
Publicado: (2020) -
Functional characterization of dopamine and norepinephrine transport across the apical and basal plasma membranes of the human placental syncytiotrophoblast
por: Horackova, Hana, et al.
Publicado: (2022) -
Mutations of tyrosine 467 in the human norepinephrine transporter attenuate HIV-1 Tat-induced inhibition of dopamine transport while retaining physiological function
por: Strauss, Matthew J., et al.
Publicado: (2022) -
Norepinephrine transporter promotes the invasion of human colon cancer cells
por: Zhang, Huahua, et al.
Publicado: (2020)